Literature DB >> 24145888

Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the Canadian Fluoroscopy Cohort Study.

Lydia B Zablotska, Mark P Little, R Jack Cornett.   

Abstract

Risks of noncancer causes of death, particularly cardiovascular disease, associated with exposures to high-dose ionizing radiation, are well known. Recent studies have reported excess risk in workers who are occupationally exposed to low doses at a low dose rate, but the risks of moderately fractionated exposures, such as occur during diagnostic radiation procedures, remain unclear. The Canadian Fluoroscopy Cohort Study includes 63,707 tuberculosis patients exposed to multiple fluoroscopic procedures in 1930-1952 and followed-up for death from noncancer causes in 1950-1987. We used a Poisson regression to estimate excess relative risk (ERR) per Gy of cumulative radiation dose to the lung (mean dose = 0.79 Gy; range, 0-11.60). The risk of death from noncancer causes was significantly lower in these subjects compared with the Canadian general population (P < 0.001). We estimated small, nonsignificant increases in the risk of death from noncancer causes with dose. We estimated an ERR/Gy of 0.176 (95% confidence interval: 0.011, 0.393) (n = 5,818 deaths) for ischemic heart disease (IHD) after adjustment for dose fractionation. A significant (P = 0.022) inverse dose fractionation effect in dose trends of IHD was observed, with the highest estimate of ERR/Gy for those with the fewest fluoroscopic procedures per year. Radiation-related risks of IHD decreased significantly with increasing time since first exposure and age at first exposure (both P < 0.05). This is the largest study of patients exposed to moderately fractionated low-to-moderate doses of radiation, and it provides additional evidence of increased radiation-associated risks of death from IHD, in particular, significantly increased radiation risks from doses similar to those from diagnostic radiation procedures. The novel finding of a significant inverse dose-fractionation association in IHD mortality requires further investigation.

Entities:  

Keywords:  cardiovascular disease; dose fractionation; ionizing radiation; ischemic heart disease; noncancer diseases; radiation dose-response relationship

Mesh:

Year:  2013        PMID: 24145888      PMCID: PMC3864716          DOI: 10.1093/aje/kwt244

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

1.  Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; S Lewington; M Walker; L Lennon; A Thomson; Y-K Wong; X Zhou; M Ward
Journal:  Eur Heart J       Date:  2002-03       Impact factor: 29.983

2.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.

Authors:  Amy Berrington de González; Sarah Darby
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

3.  Organ dose per unit exposure resulting from fluoroscopy for artificial pneumothorax.

Authors:  G J Sherman; G R Howe; A B Miller; M Rosenstein
Journal:  Health Phys       Date:  1978-08       Impact factor: 1.316

4.  A generalized iterative record linkage computer system for use in medical follow-up studies.

Authors:  G R Howe; J Lindsay
Journal:  Comput Biomed Res       Date:  1981-08

5.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

6.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

Authors:  J Cuzick; H Stewart; L Rutqvist; J Houghton; R Edwards; C Redmond; R Peto; M Baum; B Fisher; H Host
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

7.  Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study.

Authors:  G R Howe
Journal:  Radiat Res       Date:  1995-06       Impact factor: 2.841

8.  Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts.

Authors:  J D Boice; D Preston; F G Davis; R R Monson
Journal:  Radiat Res       Date:  1991-02       Impact factor: 2.841

9.  Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis.

Authors:  A B Miller; G R Howe; G J Sherman; J P Lindsay; M J Yaffe; P J Dinner; H A Risch; D L Preston
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

10.  Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients.

Authors:  F G Davis; J D Boice; Z Hrubec; R R Monson
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

View more
  16 in total

Review 1.  A New Era of Low-Dose Radiation Epidemiology.

Authors:  Cari M Kitahara; Martha S Linet; Preetha Rajaraman; Estelle Ntowe; Amy Berrington de González
Journal:  Curr Environ Health Rep       Date:  2015-09

2.  Ischaemic heart disease incidence and mortality in an extended cohort of Mayak workers first employed in 1948-1982.

Authors:  Tamara V Azizova; Evgeniya S Grigoryeva; Richard G E Haylock; Maria V Pikulina; Maria B Moseeva
Journal:  Br J Radiol       Date:  2015-07-30       Impact factor: 3.039

3.  Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study.

Authors:  Mark P Little; Lydia B Zablotska; Alina V Brenner; Steven E Lipshultz
Journal:  Eur J Epidemiol       Date:  2015-08-09       Impact factor: 8.082

4.  Fluoroscopy X-Ray Organ-Specific Dosimetry System (FLUXOR) for Estimation of Organ Doses and Their Uncertainties in the Canadian Fluoroscopy Cohort Study.

Authors:  A Iulian Apostoaei; Brian A Thomas; F Owen Hoffman; David C Kocher; Kathleen M Thiessen; David Borrego; Choonsik Lee; Steven L Simon; Lydia B Zablotska
Journal:  Radiat Res       Date:  2021-04-01       Impact factor: 2.841

5.  Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies.

Authors:  Mark P Little; Richard Wakeford; David Borrego; Benjamin French; Lydia B Zablotska; M Jacob Adams; Rodrigue Allodji; Florent de Vathaire; Choonsik Lee; Alina V Brenner; Jeremy S Miller; David Campbell; Mark S Pearce; Michele M Doody; Erik Holmberg; Marie Lundell; Siegal Sadetzki; Martha S Linet; Amy Berrington de González
Journal:  Lancet Haematol       Date:  2018-07-17       Impact factor: 18.959

Review 6.  Radiation and circulatory disease.

Authors:  Mark P Little
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-30       Impact factor: 5.657

7.  Radio-biologically motivated modeling of radiation risks of mortality from ischemic heart diseases in the Canadian fluoroscopy cohort study.

Authors:  Helmut Schöllnberger; Jan Christian Kaiser; Markus Eidemüller; Lydia B Zablotska
Journal:  Radiat Environ Biophys       Date:  2019-11-28       Impact factor: 1.925

Review 8.  Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer.

Authors:  Christopher B Sylvester; Jun-Ichi Abe; Zarana S Patel; K Jane Grande-Allen
Journal:  Front Cardiovasc Med       Date:  2018-01-31

9.  Analysis of mortality in a pooled cohort of Canadian and German uranium processing workers with no mining experience.

Authors:  Lydia B Zablotska; Nora Fenske; Maria Schnelzer; Sergey Zhivin; Dominique Laurier; Michaela Kreuzer
Journal:  Int Arch Occup Environ Health       Date:  2017-09-22       Impact factor: 3.015

10.  Radiation-associated circulatory disease mortality in a pooled analysis of 77,275 patients from the Massachusetts and Canadian tuberculosis fluoroscopy cohorts.

Authors:  Van Tran; Lydia B Zablotska; Alina V Brenner; Mark P Little
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.